by Brooks | Aug 4, 2025 | News, Rare disease
This is an excerpt of Jura Health’s Chris Moore and UGenome’s Zachary Brooks Thought Leadership Article that appeared in MedCity News on July 29, 2025. By leveraging select pharmacogenomic tools, physicians can minimize off-target effects of medications...
by Brooks | May 30, 2025 | News, Nutrigenomics, Pediatrics-children, Pharmacogenomics, Precision Health Personalized Medicine, Rare disease
May 30, 2025 TUCSON, AZ – UGenome AI, a pioneer in genomic technology, today announced an expanded partnership with Jura Health, Inc. to integrate both pharmacogenomic and nutrigenomic insights into the diagnosis of rare diseases and the development of personalized...
by Brooks | Apr 16, 2025 | Emerging Trends, Rare disease
Chris Moore, MBA & Jayden Lee, EMBA, BCACP, PharmD Pharmacogenomics in Rare Disease: Challenges and Opportunities. How rare is rare? In the U.S. alone, around 30 million people – roughly 1 in 10 – live with a rare disease (Rare Disease, NIH, 2025). 80% of rare...
by Brooks | Dec 28, 2024 | Emerging Trends, Rare disease
Jennifer Tovar, PharmD & Husna Rahim, PharmD Can pharmacogenomics (PGx) reshape the diagnosis and treatment of rare diseases? Rare diseases, as the name implies, affect a small portion of the population. PGx offers a new avenue for precision medicine in rare...
